Role of Pentoxifylline in Severe Alcoholic Hepatitis

Rasmirekha Behera
2016 Journal of Medical Science And clinical Research  
AIM: Role of Pentoxifylline is compared with placebo in the treatment of Severe Alcoholic Hepatitis. METHODS: Total 20 pts with severe alcoholic hepatitis (Maddrey DF ≥ 32) were included in the study.10 patients received pentoxifylline 400mg TDS for 4wks.And 10 patients received placebo for 4 wks. Baseline characteristics of the two groups were similar. Study was conducted for 4 wks. RESULT: Statistical Analysis was done using student's t test. The calculated t value found to be 25.01 at 18 df
more » ... hich indicates the difference between Placebo and Pentoxyfylline group is highly significant (P<0.001). Higher baseline Maddrey Discriminant Function was associated with increased mortality. But Pentoxifylline lowers the Maddrey Discriminant Function thus improves survival. CONCLUSION: As compared to Placebo, Pentoxifylline reduce mortality, improved risk-benefit profile and lowers Maddrey Discriminant Function in patients with severe alcoholic hepatitis. Hence it is suggested that pentoxifylline is efficacious in treatment of severe alcoholic hepatitis.
doi:10.18535/jmscr/v4i9.30 fatcat:qsitc4oa5bghxpoedzrz4kqijy